FDA approves Elon Musk’s Neuralink implants for humans test
The brain-implant company Neuralink, co-founded by billionaire entrepreneur Elon Musk, has received approval from the US Food and Drug Administration (FDA) to begin testing its technology on humans. The company’s brain chip interfaces are designed to give paralyzed and neurologically-disabled patients the ability to move and communicate again, and could also restore vision. Neuralink first announced its plans to host human clinical trials in December 2021, and has since received FDA approval to begin conducting such trials. While Musk has hailed the FDA’s approval as a crucial step towards helping people, some have raised concerns about the invasive nature of the technology.
FAQs
What is Neuralink?
Neuralink is a brain-implant company co-founded by billionaire entrepreneur Elon Musk. The company is developing brain chip interfaces designed to give paralyzed and neurologically-disabled patients the ability to move and communicate again, and may also restore vision.
What FDA approval did Neuralink receive?
Neuralink has received FDA approval to begin conducting clinical trials on humans for its brain-implant technology.
Why are people concerned about the invasive nature of the technology?
Some have raised concerns that the technology is too intrusive and could pose risks to patients. There have also been calls for legislation to regulate Neuralink’s use of the technology.
When did Neuralink first announce its plans to host human clinical trials?
Neuralink first announced its plans to host human clinical trials in December 2021.
What did Elon Musk say about the FDA approval?
Musk hailed the FDA’s approval as a crucial step towards helping people.
The Neuralink Implants by Elon Musk have been approved by the FDA for human trials.
Neuralink, the brain-implant company founded by billionaire entrepreneur Elon Musk, has received approval from the US Food and Drug Administration to start human testing of its technology. The company has been developing brain chip interfaces that could help patients with neurological conditions move and communicate again. Musk has previously suggested that the tech could also restore sight. Neuralink announced on Twitter that it had received the FDA’s approval for its first-in-human clinical study, which followed months of work in collaboration with the regulator. Some social media users expressed concerns about the invasive nature of the proposed implant, with some calling for legislative regulation.